JPH06500771A - モノクローナル抗体の新規な用途 - Google Patents

モノクローナル抗体の新規な用途

Info

Publication number
JPH06500771A
JPH06500771A JP3514194A JP51419491A JPH06500771A JP H06500771 A JPH06500771 A JP H06500771A JP 3514194 A JP3514194 A JP 3514194A JP 51419491 A JP51419491 A JP 51419491A JP H06500771 A JPH06500771 A JP H06500771A
Authority
JP
Japan
Prior art keywords
monoclonal antibody
antibody
cells
specificity
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3514194A
Other languages
English (en)
Japanese (ja)
Inventor
ロイブナー、ハンス
Original Assignee
ノバーティス　アクチエンゲゼルシャフト
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノバーティス　アクチエンゲゼルシャフト filed Critical ノバーティス　アクチエンゲゼルシャフト
Publication of JPH06500771A publication Critical patent/JPH06500771A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C07K16/114—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
JP3514194A 1990-08-11 1991-08-08 モノクローナル抗体の新規な用途 Pending JPH06500771A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4025499A DE4025499A1 (de) 1990-08-11 1990-08-11 Verwendung der antikoerper br55-2, deren derivate, konjugate und fragmente zur bekaempfung von hiv-infektionen
DE4025499.2 1990-08-11

Publications (1)

Publication Number Publication Date
JPH06500771A true JPH06500771A (ja) 1994-01-27

Family

ID=6412074

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3514194A Pending JPH06500771A (ja) 1990-08-11 1991-08-08 モノクローナル抗体の新規な用途

Country Status (13)

Country Link
EP (1) EP0547079B1 (enExample)
JP (1) JPH06500771A (enExample)
KR (1) KR930701193A (enExample)
AT (1) ATE136469T1 (enExample)
AU (1) AU657489B2 (enExample)
CA (1) CA2088370C (enExample)
DE (2) DE4025499A1 (enExample)
HU (1) HUT64238A (enExample)
IE (1) IE912823A1 (enExample)
PT (1) PT98622A (enExample)
TW (1) TW223019B (enExample)
WO (1) WO1992003165A1 (enExample)
ZA (1) ZA916313B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69230545T2 (de) * 1991-08-21 2000-07-06 Novartis Ag, Basel Antikörperderivate
CA2134751C (en) * 1992-05-22 2003-12-16 Helmut Eckert Monoclonal antibodies and their use
EP1091763B1 (de) * 1998-06-29 2003-09-17 Wolfgang Bergter Antivirale und antiretrovirale radioimmunpharmaka auf der basis von alpha- und beta-strahlern

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU592142B2 (en) * 1985-11-25 1990-01-04 Cytogen Corporation Modified viral glycoproteins, diagnostic and therapeutic uses therefore
JPH083487B2 (ja) * 1987-07-31 1996-01-17 株式会社日本抗体研究所 異常応答リンパ球の検出方法並びにこれに用いる検出用試薬及びキット

Also Published As

Publication number Publication date
IE912823A1 (en) 1992-02-12
AU8393291A (en) 1992-03-17
DE4025499A1 (de) 1992-02-13
EP0547079B1 (en) 1996-04-10
HU9300349D0 (en) 1993-05-28
AU657489B2 (en) 1995-03-16
HUT64238A (en) 1993-12-28
DE69118702D1 (de) 1996-05-15
EP0547079A1 (en) 1993-06-23
PT98622A (pt) 1992-06-30
CA2088370A1 (en) 1992-02-12
TW223019B (enExample) 1994-05-01
ATE136469T1 (de) 1996-04-15
DE69118702T2 (de) 1996-09-05
CA2088370C (en) 2003-03-25
ZA916313B (en) 1993-04-28
KR930701193A (ko) 1993-06-11
WO1992003165A1 (en) 1992-03-05

Similar Documents

Publication Publication Date Title
AU2003215900B2 (en) Anti-human tenascin monoclonal antibody
CA2090317A1 (en) Homoconjugated immunoglobulins
JP2006056907A (ja) 細胞および血清タンパク質アンカー並びに接合体
AU677221B2 (en) A monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
US6030796A (en) Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
AU698908B2 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
US20050014230A1 (en) Preparation of fully human antibodies
JPH10509948A (ja) Ｔ細胞受容体ペプチドに対するヒト抗体およびそれらの調製方法
JPH06500771A (ja) モノクローナル抗体の新規な用途
JPH05506142A (ja) Ｈｉｖ蛋白質の非免疫支配エピトープに特異的なモノクローナル抗体
RU2208642C2 (ru) МОНОКЛОНАЛЬНОЕ АНТИИДИОТИПИЧЕСКОЕ АНТИТЕЛО Ab2, СПОСОБ ЕГО ПОЛУЧЕНИЯ, ИСПОЛЬЗОВАНИЯ ПРОТИВ БОЛЕЗНЕЙ, СОПРОВОЖДАЮЩИХСЯ ЭКСПРЕССИЕЙ Lewis Y6 АНТИГЕНА, И ДЛЯ ОЧИСТКИ ВАРИАНТА BR55-2 АНТИТЕЛА, ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКИЙ СОСТАВ
JPS63294795A (ja) ヒト免疫不全ウイルス（ｈｉｖ）の検出と治療のための方法および物質
US6190863B1 (en) Sugar chain-recognizing antibodies and remedies for HIV infectious diseases
JP2996526B2 (ja) モノクローナル抗体の新用途
JPH05506843A (ja) 抗―炭水化物抗体及び炭水化物抗原に作用する後天性免疫不全症候群（ａｉｄｓ）及びａｉｄｓ関連複合体（ａｒｃ）の薬剤及び治療法
EP0450573A2 (en) Antibodies for the treatment and diagnosis of Pseudomonas aeruginosa infections
CA2239596C (en) Sugar-chain-recognizing antibodies and remedies for hiv infectious diseases